The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

 
Web www.patentalert.com

< Viscous fat compositions having low amounts of trans-fat, methods and products

< Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same

> Aryl sulfonamide compounds for treating obesity

> Quinazoline derivatives and medicaments

~ 00608